PRR5 encodes a conserved proline-rich protein predominant in kidney: Analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas

Genomics

Volumn 85, Issue 3, 2005, Pages 338-351

  Johnstone, Cameron N ^a,b   Castellví Bel, Sergi ^c   Chang, Laura M ^a,b   Sung, Raphael K ^a,b   Bowser, Mark J ^a,b   Piqué, Josep M ^c   Castells, Antoni ^c   Rustgi, Anil K ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

5 RACE PCR; Alternative promoter; Alternative splicing; Breast cancer; Colorectal cancer; CpG island; Methylation; PCR SSCP analysis; Proline; PRR5

Indexed keywords

5' AZA 2' DEOXYCYTIDINE; DEOXYCYTIDINE; ISOPROTEIN; MESSENGER RNA; PROLINE; PSEUDO RESPONSE REGULATOR 5; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CHROMOSOME 22Q; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CODE; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; SOMATIC MUTATION; STRUCTURAL GENOMICS; TUMOR SUPPRESSOR GENE;

EID: 13844254274     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygeno.2004.11.002     Document Type: Article

References (41)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
2. R.A. Gatenby, and T.L. Vincent An evolutionary model of carcinogenesis Cancer Res. 63 2003 6212 6220
3. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
4. S.D. Markowitz, D.M. Dawson, J. Willis, and J.K. Willson Focus on colon cancer Cancer Cell 1 2002 233 236
5. A. Balmain, J. Gray, and B. Ponder The genetics and genomics of cancer Nat. Genet. 33 2003 238 244
6. J.R. Pollack Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors Proc. Natl. Acad. Sci. USA 99 2002 12963 12968
7. B. Vogelstein Allelotype of colorectal carcinomas Science 244 1989 207 211
8. W.K. Cavenee Expression of recessive alleles by chromosomal mechanisms in retinoblastoma Nature 305 1983 779 784
9. S.J. Baker p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis Cancer Res. 50 1990 7717 7722
10. J.G. Herman Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc. Natl. Acad. Sci. USA 95 1998 6870 6875
11. E.E. Cameron, K.E. Bachman, S. Myohanen, J.G. Herman, and S.B. Baylin Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat. Genet. 21 1999 103 107
12. A.G. Knudson Two genetic hits (more or less) to cancer Nat. Rev. Cancer 1 2001 157 162
13. The European Consortium on MEN-1 The search for the MEN1 gene J. Intern. Med. 243 1998 441 446
14. L. Burke Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer Cancer Res. 58 1998 2533 2536
15. G. Berx E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers EMBO J. 14 1995 6107 6115
16. A. Castells, J.F. Gusella, V. Ramesh, and A.K. Rustgi A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers Cancer Res. 60 2000 2836 2839
17. A. Iida Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer Genes Chromosomes Cancer 21 1998 108 112
18. A. Castells Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer Gastroenterology 117 1999 831 837
19. C.Z. Zhou, Z.H. Peng, F. Zhang, G.Q. Qiu, and L. He Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma World J. Gastroenterol. 8 2002 668 673
20. W. Cliby Human epithelial ovarian cancer allelotype Cancer Res. 53 1993 2393 2398
21. R.C. Poli-Frederico Chromosome 22q a frequent site of allele loss in head and neck carcinoma Head Neck 22 2000 585 590
22. P.P. dos Reis Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas Med. Sci. Monit. 8 2002 BR89 BR94
23. A. Miyakawa Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13 Int. J. Oncol. 13 1998 705 709
24. L. Du Plessis Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the black and colored populations of South Africa Cancer Res. 59 1999 1877 1883
25. D.J. Marsh Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma J. Clin. Endocrinol. Metab. 88 2003 1866 1872
26. C. Hartmann Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma Int. J. Cancer 108 2004 839 844
27. B. Klamt Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters Genes Chromosomes Cancer 22 1998 287 294
28. C.N. Johnstone ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers Gene 336 2004 59 71
29. E. Korenbaum, T.M. Olski, and A.A. Noegel Genomic organization and expression profile of the parvin family of focal adhesion proteins in mice and humans Gene 279 2001 69 79
30. Z. Shan, T. Haaf, and N.C. Popescu Identification and characterization of a gene encoding a putative mouse Rho GTPase activating protein gene 8, Arhgap8 Gene 303 2003 55 61
31. X. Shang, Y.T. Zhou, and B.C. Low Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1 J. Biol. Chem. 278 2003 45903 45914
32. D.P. Dickinson, and M. Thiesse cDNA cloning of an abundant human lacrimal gland mRNA encoding a novel tear protein Curr. Eye Res. 15 1996 377 386
33. S. Isemura, and E. Saitoh Molecular cloning and sequence analysis of cDNA coding for the precursor of the human salivary proline-rich peptide P-B J. Biochem. (Tokyo) 115 1994 1101 1106
34. S. Isemura, and E. Saitoh Nucleotide sequence of gene PBI encoding a protein homologous to salivary proline-rich protein P-B J. Biochem. (Tokyo) 121 1997 1025 1030
35. M. Kozak Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs Nucleic Acids Res. 12 1984 857 872
36. S. Castellvi-Bel, A. Castells, C.N. Johnstone, V. Pinol, M. Pellise, J.I. Elizalde, N. Romo, A.K. Rustgi, and J.M. Pique Evaluation of PARVG located on 22q13 as a candidate tumor suppressor gene for colorectal and breast cancer Cancer Genet. Cytogenet. 144 2003 80 82
37. R.H. Whitehead, A. Brown, and P.S. Bhathal A method for the isolation and culture of human colonic crypts in collagen gels In Vitro Cell Dev. Biol. 23 1987 436 442
38. J.T. den Dunnen, and S.E. Antonarakis Nomenclature for the description of human sequence variations Hum. Genet. 109 2001 121 124
39. M. Lacroix, and G. Leclercq Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res. Treat. 83 2004 249 289
40. T. Naka, M. Kobayashi, K. Ashida, N. Toyota, T. Kaneko, and N. Kaibara Aberrant p16INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer Int. J. Oncol. 12 1998 1111 1116
41. C.Y. Dai, E.E. Furth, R. Mick, J. Koh, T. Takayama, Y. Niitsu, and G.H. Enders p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation Gastroenterology 119 2000 929 942